SNCA and Parkinson disease: Here, we reported significant epigenetic deregulation of the SNCA gene in PD and a novel strategy that efficiently ameliorated expression of α‐synuclein by editing pathological epigenetic marks in differentiated iPSCs derived from idiopathic PD patients.